Speakers from Block 2 'Health' raised the main issues about cannabis in pain treatment, oncology, and for the elderly

In Brazil alone, the medicinal market is expected to reach over R$ 600 million in 2023, according to a report by the data intelligence company Kaya Mind

The largest scientific/professional events in Brazil and Latin America on the medicinal use of cannabis highlight the latest trends and news from one of the fastest-growing markets in the world.

The plant is considered a viable alternative treatment in Southeast Asia

The Federal Bill that authorizes and sets regulations for cultivation and other issues, PL399/2015, is still pending. Some municipalities have already implemented their initiatives on the subject since 2021. Now, with the law sanctioned in the state of São Paulo and

How can the debate on the uses of cannabis be expanded in Brazil?

The agency's goal is to strengthen transparency initiatives, providing updated content and knowledge to the public

Professional council recognizes the therapeutic properties of cannabis in animals, but states that professionals still do not have legal certainty to prescribe

Four experts report on the various experiences of cultivating cannabis for medicinal and industrial purposes in Brazil and abroad, mapping best practices and the main difficulties for the development of the activity

STJ's decision could limit health plan coverage to only the procedures listed by the National Health Agency (ANS)

On the anniversary of the National Health Surveillance Agency (Anvisa), learn about the evolution of the medicinal use of cannabis over the 23 years since the agency was created

Course aimed at veterinarians who want to learn more about cannabis will feature Erik Amazonas as a lecturer

With a focus on security and immigration, the new Chilean government remains silent on cannabis and increases regulatory uncertainties in the country

37% discount on CBCM 2026 tickets ends on April 1st; interested parties have only 7 days to secure participation with reduced prices

5th edition of Cannabis Fair Brazil will be at Transamerica Expo Center and reinforces sector advancement, from May 21 to 23, in São Paulo

Advances by Anvisa in 2026 reinforce debate on research and public policies in the sector

Accelerated growth of the German market reveals global competition for prices and leadership in the supply chain

Luis Alfonso Londoño Zapata shares his journey in the regulated cannabis market in Colombia and analyzes business opportunities in Latin America.

Episode addresses the update of RDC 660, international certification, and challenges to expand access to treatments with different cannabinoids in Brazil.

In an interview with the CB.Poder program of Correio Brasiliense, conducted by journalists Adriana Bernardes and Sibele Negromonte, Leandro Safatle, acting CEO of Anvisa, detailed the behind-the-scenes and expectations regarding the new regulation of medicinal cannabis and research in Brazil